Mediq
Dutch healthcare services and medical-supply company serving patients, pharmacies, healthcare professionals, and institutions.
Last updated August 31, 2026
AI crawler reads
4requests
1companies- Anthropic4
- Profile
- 2
- Controversies
- 0
- JSON · MD
- 0
- First read
- Nov 4, 2026
- Latest read
- Nov 4, 2026
From this site's server log
Overview
Mediq is a Dutch healthcare services company focused on the distribution of pharmaceuticals, medical devices, and related care products. Its activities combine pharmacy operations with the direct delivery of medical supplies to patients at home and the institutional supply of healthcare products to medical centres, professionals, and healthcare organizations. This model places Mediq between a traditional pharmacy operator, a pharmaceutical wholesaler, and a specialist medical-supply provider. The company traces its origins to 1899, when a group of apothecaries established the Onderlinge Pharmaceutische Groothandel, or Mutual Pharmaceutical Wholesale Company. The cooperative was created by pharmacists who wanted medicines to be supplied through authorized professional channels rather than by unauthorized sellers. In its early period, the organization also produced pharmaceuticals on a small scale. As its activities expanded, the cooperative adopted the name Coöperatieve Apothekers Vereniging OPG U.A. in 1988. Although the word wholesale was removed from the formal name, the abbreviation OPG remained associated with the business. Mediq entered the public markets in 1992. On 10 January 2001, the cooperative was converted into a public limited company under the name OPG Groep NV. The company adopted the Mediq name in 2009 as part of a broader effort to present its pharmacy, pharmaceutical distribution, and healthcare-supply activities under one international brand. Its business subsequently developed beyond conventional pharmacy retail toward direct-to-patient care and specialized distribution of medical devices. A strategic review in 2011 concluded that leaving the stock exchange and operating as a privately owned company could support Mediq's longer-term direction. Advent International expressed an interest in acquiring the company in 2012 and completed the purchase of its shares in February 2013. Mediq was delisted in March 2013. The transaction changed the company's ownership structure while leaving its Direct & Institutional division, which supplied medical devices and care products, within Mediq. The company has expanded its specialist healthcare-distribution platform through acquisitions. Byram Healthcare, its American subsidiary, was sold in 2017. In the same year Mediq acquired ACC Nordic AS and ACC Nordic AB, strengthening its Nordic presence. In 2019 it acquired Puls, a distributor of medical products and equipment serving Norway and Denmark. Since March 2020, H&R Healthcare Ltd, an English distributor specializing in wound-care products, has also formed part of the group. These transactions support a strategy of supplying medical devices directly to patients, healthcare professionals, and healthcare institutions, particularly in European markets. In the Netherlands, Mediq has operated its own pharmacy network, supplemented by franchise pharmacies and wholesale supply to independently operated pharmacies. The company has also maintained operations across Northern, Western, Central, and Eastern Europe, as well as the United States. Its historical activities included approximately 226 owned Dutch pharmacies, around 25 franchise locations, and supply relationships with roughly 160 additional pharmacies. The precise scale and geographic composition of the business may have changed over time, but Mediq's core positioning remains the integration of pharmaceutical access with homecare and institutional medical-supply services.
History
Mediq began in 1899 as Onderlinge Pharmaceutische Groothandel, a cooperative founded by apothecaries who sought to preserve professional control over medicine distribution. The organization initially supplied medicines through its member network and also produced pharmaceuticals on a limited scale. Its cooperative identity reflected the concerns of pharmacists who did not want medicines distributed by unauthorized parties. In 1988, the organization was renamed Coöperatieve Apothekers Vereniging OPG U.A. The formal name no longer explicitly referred to wholesale, although OPG remained the recognizable abbreviation. A major structural change followed in 1992, when the company became listed on the Amsterdam Stock Exchange. On 10 January 2001, the cooperative was converted into a public limited company named OPG Groep NV. The company adopted the Mediq name in 2009. The rebranding reflected the development of a broader healthcare platform encompassing pharmacy operations, pharmaceutical distribution, medical devices, and care-related services. Rather than limiting itself to medicine wholesaling, Mediq increasingly sought to serve patients directly and supply healthcare professionals and institutions with specialized products. A 2011 strategic analysis led Mediq to consider private ownership preferable for its long-term plans. Advent International showed interest in the company in 2012 and completed the acquisition of its shares on 13 February 2013. Mediq was subsequently removed from the stock market on 13 March 2013. The privately owned company retained its Direct & Institutional division, which focused on medical devices and care provision. Mediq's later development included both portfolio changes and geographic expansion. Its American subsidiary, Byram Healthcare, was sold in 2017. In June of that year, Mediq acquired ACC Nordic AS and ACC Nordic AB. In May 2019, it acquired Puls, a medical-products and equipment distributor in Norway and Denmark. H&R Healthcare Ltd, an English distributor of wound-care products, became part of Mediq in March 2020. These acquisitions were consistent with a strategy of direct supply to patients, healthcare professionals, and healthcare institutions in Europe. Historically, the company operated a substantial pharmacy network in the Netherlands, including owned pharmacies and franchise locations, while also supplying independent pharmacies. Its international footprint included the Netherlands, Poland, Germany, Denmark, Belgium, Sweden, Norway, France, Finland, Hungary, Switzerland, Estonia, Latvia, Lithuania, and the United States. Mediq's business therefore evolved from a pharmacist-led cooperative into a multinational healthcare-services and medical-supply group.
- 2020
Added H&R Healthcare
[1]English wound-care distributor H&R Healthcare Ltd joined Mediq, broadening its specialist care-product portfolio.
- 2019
Acquired Puls
[1]The acquisition of Norwegian and Danish distributor Puls strengthened Mediq's Nordic medical-equipment distribution.
- 2017
Expanded Nordic operations and sold Byram Healthcare
[1]Mediq acquired ACC Nordic AS and ACC Nordic AB while divesting its American subsidiary Byram Healthcare.
- 2013
Became privately owned
[1]Advent International completed its acquisition, and Mediq was delisted from the stock market in March.
- 2009
Adopted the Mediq name
[1]OPG Groep changed its name to Mediq NV as it broadened its healthcare and medical-supply positioning.
- 2001
Converted into OPG Groep NV
[1]On 10 January, the cooperative became a public limited company under the name OPG Groep NV.
- 1992
Listed on the Amsterdam Stock Exchange
[1]The company entered the public markets, beginning its period as a listed healthcare and pharmaceutical-services business.
- 1988
Renamed Coöperatieve Apothekers Vereniging OPG U.A.
[1]The organization adopted a new cooperative name as its activities expanded, while retaining OPG as its identifying abbreviation.
- 1899
Formation as Onderlinge Pharmaceutische Groothandel
[1]A cooperative association of apothecaries established the Mutual Pharmaceutical Wholesale Company to distribute medicines through authorized professional channels.
Products and positioning
An integrated healthcare-access and medical-supply provider combining pharmacy services, pharmaceutical distribution, home delivery, and institutional supply. Mediq emphasizes direct provision of medical devices and care products to patients and healthcare professionals rather than operating solely as a conventional pharmacy chain.
Pharmaceuticals
Pharmacy medicines
Mediq's traditional business includes the retail and distribution of pharmaceutical medicines through its own pharmacy operations, franchise relationships, and supply to other pharmacies. This activity developed from the company's original pharmacist cooperative model and remains one component of its broader healthcare-access platform.
Medical supplies
Medical devices and homecare supplies
Mediq supplies medical devices and care products directly to patients, including products used in home-based care. The Direct & Institutional division was retained after the 2013 ownership change and represents the company's move beyond conventional pharmacy retail toward specialist, patient-oriented healthcare logistics.
Healthcare distribution
Institutional healthcare supply
The company delivers pharmaceuticals, medical devices, and related healthcare products to medical centres, healthcare professionals, and institutions. This service connects manufacturers and professional users while supporting recurring supply requirements in clinical and care environments.
Specialist medical supplies · 2020
Wound-care products
Through H&R Healthcare, Mediq expanded its specialist distribution capabilities in wound-care products. The business supports the supply of wound-care goods to relevant healthcare users and complements Mediq's broader direct-to-patient and professional medical-supply activities.
Brand decisions
2019
Acquired PulsM&ABackground
Mediq continued building a European distribution network for medical products and equipment.
Action taken
Mediq acquired Puls, a distributor operating in Norway and Denmark.
Aftermath
The acquisition strengthened Mediq's Nordic distribution capabilities.
2017
Rebalanced the international portfolioM&ABackground
Mediq sought to concentrate on direct medical-device and care-product supply, particularly in Europe.
Action taken
The company sold Byram Healthcare in the Americas while acquiring ACC Nordic AS and ACC Nordic AB.
Aftermath
The transactions reduced the American subsidiary footprint and expanded Mediq's Nordic platform.
2013
Accepted Advent International acquisitionM&ABackground
Advent International expressed interest in Mediq during the company's review of its ownership and long-term strategy.
Action taken
Advent International bought Mediq's shares on 13 February 2013, and the company left the stock market on 13 March 2013.
Aftermath
Mediq continued as a privately owned healthcare-supply group, retaining its Direct & Institutional division.
2011
Pursued a privately owned structureStrategyBackground
A tactical analysis concluded that leaving the stock exchange could provide the best long-term strategic setting for Mediq.
Action taken
Mediq opened the way for an acquisition by a private-equity owner rather than continuing as a listed company.
Aftermath
Advent International subsequently acquired the company, and Mediq was delisted in March 2013.
Recent events
Sources2 sources
Cite this profile: Cite the canonical profile. /brand-wiki/mediq · Editorial policy · How profiles are compiled